A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02434497 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia (HoFH)

Interventions

DRUG: Rosuvastatin 20mg

Sponsor

AstraZeneca